| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
President And CEO | Director | Former Director
3 companies
Boyce Sarah is a President And CEO at Avidity Biosciences, Inc. with holdings across 3 companies. Recent SEC Form 4 filings include 0 buys and 11 sells.
Estimated insider holdings value: $4.5M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jan 7, 2026 | RNA Avidity Biosciences, Inc. | President And CEO | Sell | 8,576 | $72.23 | $619,444.48 | -2.9% | |
| Sep 5, 2025 | RNA Avidity Biosciences, Inc. | President And CEO | Sale+OE | 50,000 | $49.95 | $2,497,435.00 | -14.1% | |
| Aug 28, 2025 | RNA Avidity Biosciences, Inc. | President And CEO | Sale+OE | 25,000 | $49.39 | $1,234,700.00 | -7.6% | |
| Mar 20, 2025 | RNA Avidity Biosciences, Inc. | President And CEO | Sell | 31,540 | $31.06 | $979,563.01 | -9.3% | |
| Jan 21, 2025 | RNA Avidity Biosciences, Inc. | President And CEO | Sell | 10,397 | $28.59 | $297,291.42 | -1.5% | |
| Dec 18, 2024 | RNA Avidity Biosciences, Inc. | President And CEO | Sell | 31,855 | $32.66 | $1,040,384.30 | -10.7% | |
| Sep 23, 2024 | RNA Avidity Biosciences, Inc. | President And CEO | Sell | 32,880 | $44.00 | $1,446,723.29 | -12.3% | |
| Aug 6, 2024 | RNA Avidity Biosciences, Inc. | President And CEO | Sale+OE | 28,000 | $43.35 | $1,213,822.40 | -12.0% | |
| Jul 9, 2024 | RNA Avidity Biosciences, Inc. | President And CEO | Sale+OE | 28,000 | $39.93 | $1,118,082.00 | -12.0% | |
| Jun 18, 2024 | RNA Avidity Biosciences, Inc. | President And CEO | Sell | 32,074 | $39.13 | $1,255,039.58 | -18.4% |